Both enantiomers of novel perfluoroalkane-tagged 5,5-diphenyl-2-oxazolidinone (DIOZ) auxiliaries have been prepared using a two-step one-pot synthesis, starting from commercially available N-(tert-butoxycarbonyl)-L-valine methyl ester. The key feature of this approach is the efficient generation of a suitably active perfluoroalkyl-aryllithium species. By use of this protocol, the perfluoroalkane-tagged DIOZ auxiliaries are obtained in high enantiomeric purity and on multigram scales with overall yields exceeding 50%. The perfluoroalkane-tagged auxiliaries enable the use of fluorous solid-phase extraction, allowing efficient purification of tagged intermediates from crude reaction mixtures. The new auxiliaries have been applied in an asymmetric synthesis of β 2 -N-Fmoc-phenylalanine via a stereoselective conjugate addition.
Introduction
In the field of stoichiometric asymmetric synthesis, fluorous solid-phase extraction (FSPE) techniques have been applied to many chemical transformations, offering a powerful alternative to standard separation and purification methods. Initially proposed as a method of separating catalysts from process streams, perfluoroalkane chains have been developed as general supports for organic reagents and auxiliaries. Perfluoroalkane-tagged chiral auxiliaries are soluble in typical organic reaction solvents, and the perfluoroalkane chains are impervious to most common reagents.
Generally, minor or no modifications to the classical reaction conditions are necessary. After a reaction is complete, selective recovery of the tagged material is easily accomplished by FSPE. Several research groups from academia and industry have demonstrated that fluorous synthesis with chiral auxiliary methods is both viable and broadly applicable. For example, fluorous Evans-auxiliaries have been synthesized and applied successfully in aldol reactions and conjugate radical additions. [1] [2] [3] In this paper we report the short and efficient synthesis of perfluoroalkane tagged chiral DIOZ auxiliaries and their application to a novel synthesis of β 2 -phenylalanine. [4] [5] [6] 
Results and Discussion
Our initial approach to the synthesis was aimed at a late stage introduction of the perfluoroalkane tag to enable the use of a common intermediate in the preparation of a diverse range of auxiliaries in terms of the perfluoroalkane chain length and the manner of attachment of the tag (Scheme 1).
The oxazolidinone 3a was synthesized using a modification of the procedure described by Seebach. 4 para-Bromophenol 1a was protected with TIPS or TBDMS groups, via a standard protocol (silyl chloride, imidazole) to provide compounds 1b and 1c respectively, in nearly quantitative yields. The protected phenols were then converted into the corresponding Grignard reagents. The thus formed organo-magnesium halide species were immediately reacted with N-(tert-butoxycarbonyl)-L-valine methyl ester to deliver the tertiary alcohol intermediates 2b and 2c in good yields (87-95%).
Treatment of these open-chain intermediates with potassium tertbutoxide in THF at room temperature gave the oxazolidinones 3b and 3c in 81% and 78% yields, respectively. Deprotection with HF•pyridine afforded the free bis-phenol 3a (84-90%), which could be converted into the desired perfluoroalkane-tagged DIOZ auxiliaries either by re-protection with a freshly prepared perfluoroalkylsilyl chloride affording DIOZ 3d (59%) or alkylation with hexadecafluoro-nonane triflate to provide perfluoro-ether DIOZ 3e (43%). An alternative DIOZ auxiliary, where attachment of the perfluoroalkane tag to the phenyl rings is via a carbon-carbon bond, was synthesized from the commercially available perfluoroalkylaryl bromide 4 (R f = C 2 H 4 C 6 F 13 , Scheme 2). Compound 4 was treated with n-BuLi at low temperature to afford the corresponding metallated species and immediately allowed to react with N-(tert-butoxycarbonyl)-L-valine methyl ester, providing the tertiary alcohol 5 (82%). Surprisingly, the application of the Grignard protocol resulted in absolutely no conversion, presumably as a result of failure to initiate formation of the Grignard reagent. Treatment of the perfluoroalkane-tagged open-chain intermediate 5 with potassium tert-butoxide in THF gave the DIOZ compound 6 in 57% yield. A more expeditious version of this route involved the synthesis of DIOZ auxiliary 6 from the commercially available aryl bromide 4 via metallation, addition and cyclisation in a one-pot process. The overall yield using this most convenient route was 50%. Using the same one-pot protocol but starting with N-(tert-butoxycarbonyl)-D-valine methyl ester, afforded the optical antipode of the auxiliary, namely DIOZ ent-6.
Scheme 2. Synthesis of perfluoroalkane tagged DIOZ auxiliary 6 (R f = C 2 H 4 C 6 F 13 ).
(i) n-BuLi, THF, -78 °C, 6 h, 82%.
(ii) KOt-Bu, THF, 18 h, 0 °C-RT, 57%. (iii) n-BuLi, THF, -78 °C, 6h, then ↑ 18 ºC, 2 h, 50%.
The novel perfluoroalkane tagged chiral auxiliaries were then applied to stereoselective syntheses of a β 2 -amino acid as depicted in Scheme 3. 6, 7 A key aspect of this protocol was the application of FSPE purification techniques. As the fluorous tagged chiral auxiliaries 3d, 3e and 6 showed similar chromatographic behavior in several elution and separation experiments we choose 6 and ent-6 as auxiliaries in an asymmetric synthesis on larger scale due to the ease of synthesis. Both enantiomers of the required α,β-unsaturated imide starting material, 7 and ent-7, were prepared using a standard acylation protocol (DMAP, DIPCD, 2 eq. 2-benzylacrylic acid) in good yield (78% resolution mass spectrometric analysis, to previously reported authentic material. 8, 9 The depicted absolute stereochemistry is correlated to the chiral HPLC retention characteristics of the authentic material. The enantiomeric excess of the Fmoc-β 2 -amino acid 11 resulting from both isomers of the auxiliary was analyzed via HPLC and found to exceed 95%. 
Conclusions
The experiments described in this publication have enabled production of perfluoroalkane-tagged DIOZ chiral auxiliaries from commercially available starting materials in a one-pot operation. Application of the perfluoroalkane-tagged DIOZ auxiliaries provided a short and efficient synthesis of both enantiomeric forms of β 2 -N-Fmoc-phenylalanine (described in the Experimental Section). 14, 15 This route is distinguished by its succinctness and ease of recovery of the DIOZ auxiliary. Purification of products was achieved through silica and fluorous solidphase extractions, with only one recrystallization being required. We have performed the complete sequence on various scales, up to the formation of 25 g of the target compound in a single batch and the process requires no equipment other than typical laboratory glassware. We believe that the reported perfluoroalkane-tagged DIOZ auxiliaries are truly powerful tools for drug discovery and high-throughput chemistry and are viable alternatives to conventional or solid supported auxiliaries.
Experimental Section
General Procedures. All reagents were obtained commercially and used as received unless otherwise noted. TLC was performed on Merck silica gel plates 60 F-254, Art. no. 5729. Reverse-phase HPLC analyses were performed on an Agilent-1100 using a Macherey-Nagel CC 70/4 Nucleosil 100-3 C18 HD column, acetonitrile and water both containing 0.05% TFA, a column temperature of 35 °C, with a flow rate of 1.0 mL/min and measuring at 216 nm. The standard gradient used was 5-100% MeCN over 6 min, 100% MeCN for 1.5 min followed by 100-5% MeCN over 0.5 min. NMR was performed using a 400 MHz Varian spectrometer, AS 400 Oxford. 1 H shifts were referenced to CDCl 3 at 7.25 ppm with tetramethylsilane as internal standard for 1 H NMR. MS was measured using VG Platform (Fisons Instruments), Spectraflow 783 Detector, HP 1100 Series HPLC. Melting points were measured using a Büchi, B-545 apparatus. 
(-)-(S)-4-Isopropyl-5,5-bis-(4-triisopropylsilanyloxyphenyl)oxazolidin-2-one (3b).
The following protocol was adapted from a previously reported procedure. 4 A solution of compound 2b (44 g, 62.8 mmol) in THF (300 mL) magnetically stirred on an ice bath under an atmosphere of nitrogen, was treated with potassium tert-butoxide (8.9 g, 79.3 mmol) in one portion, and the reaction was allowed to warm slowly to RT over the course of 16 h. The resultant mixture was treated with NH 4 Cl (300 mL of a 10% w/v aqueous solution) and stirred for 10 min. The aqueous phase was separated and extracted with Et 2 O (2 x 200 mL) and the pooled organic phases were then dried (MgSO 4 ) and concentrated under reduced pressure. The resultant crude residue was purified via flash chromatography. Concentration of the appropriate fractions (R f = 0.3, 4:1 hexane / EtOAc) afforded compound 3b (33.5 g, 53.5 mmol, 81%). . A dry polyethylene bottle flushed with nitrogen was charged with a magnetic stirrer and a solution of compound 3b (17.5 g, 27.9 mmol) in THF (150 mL) and cooled in an ice bath with stirring, while HF·pyridine (35 mL of a 65-70% commercial solution) was added dropwise. The reaction was allowed to warm to RT over 16 h. The resultant mixture was diluted with diethyl ether (100 mL) and sat. aq. NaHCO 3 (500 mL). Solid NaHCO 3 was then added, in portions, until the reaction mixture was neutralised as evidenced by no more CO 2 being liberated. The organic layer was separated and the aqueous layer was extracted with 50:50 THF / diethyl ether (2 x 200 mL). The pooled organic layers were washed with brine, dried (MgSO 4 ), and concentrated under reduced pressure. The residue was purified via flash chromatography. Concentration of the appropriate fractions (R f = 0.45, 1:9 MeOH / DCM) afforded compound 3a (7.36 g, 23.5 mmol, 84%). This protocol was also used to prepare compound 3a, in similar yield, via deprotection of compound 3c. Hexadecafluoro-nonan-1-trifluoromethanesulfonate (29.58 g, 52.43 mmol) prepared as previously described 12 and Cs 2 CO 3 (21.5 g, 65.9 mmol) in DMF (140 ml) was stirred, under a nitrogen atmosphere, at a temperature of 120 ºC, for 72 h. The resultant suspension was cooled to RT, then placed on an ice bath, and treated with HCl (250 mL of a 0.5 M aqueous solution).
After stirring for 5 min, the mixture was diluted with diethyl ether (500 mL) and poured into a separation funnel. The aqueous phase was separated, and the organic phase was washed with HCl (2 x 250 mL of a 0. 1-{Hydroxy-bis-[4-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl) 9 mmol) in THF (10 mL) maintained at -78 ºC under an atmosphere of nitrogen was treated, dropwise, with n-BuLi (6.2 mL of a 1.6 M solution in hexane, 9.92 mmol) and stirring was continued at this temperature for 20 minutes. The suspension was allowed to warm to -50 ºC for 10 minutes and then cooled again to -78 ºC, before being treated, dropwise, with N-(tertbutoxycarbonyl)-L-valine methyl ester (0.93 g, 4.0 mmol) in THF (5 mL). Stirring was continued at -78 ºC for 6 h before quenching, at this temperature, with sat. aq. NH 4 Cl (25 mL). The resultant suspension was diluted with diethyl ether (50 mL). The aqueous phase was separated and the organic phase was washed sequentially with sat. aq. NH 4 Cl (40 mL) and brine (40 mL), then dried (MgSO 4 ) and concentrated under reduced pressure. The residue was purified via flash chromatography. Concentration of the appropriate fractions (R f = 0.35, 9:1 hexane / EtOAc) yielded the desired compound 5 (3.4 g, 3.25 mmol, ~82%), albeit impure due to coeluting N-(tert-butoxycarbonyl)-L-valine methyl ester starting material. This material was not characterised but rather was employed immediately in the next step. (-)-(S)-4-Isopropyl-5,5-bis-[4-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl) phenyl]-oxazolidin-2-one (6). The following protocol was adapted from a previously reported procedure. 4 A magnetically stirred solution of compound 5 (3.4 g, 3.25 mmol) maintained at 0 ºC under an atmosphere of nitrogen, was treated with potassium tert-butoxide (0.44 g, 3.9 mmol) in one portion, and the resultant mixture was allowed to slowly warm to RT over the course of 16 h. The suspension was treated with NH 4 Cl (10 mL of a 10% aqueous solution). The aqueous phase was separated and washed with diethyl ether (2 x 20 mL). The pooled organic phases were then dried and concentrated under reduced pressure. The resultant crude material was then purified via flash chromatography. Concentration of the appropriate fractions (R f = 0.3, 3:1 hexane / EtOAc) afforded compound 6 (1.8 g, 1.85 mmol, 57%). (-)-(S)-4-Isopropyl-5,5-bis-[4-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl) phenyl]-oxazolidin-2-one (6): One-pot procedure To a magnetically stirred solution of 1-bromo-4- (3,3,4,4,5,5,6,6,7,7,8,8,8 -tridecafluorooctyl)benzene (4, 40.83 g, 81.1 mmol) in THF (400 mL) maintained at -78 ºC under an atmosphere of nitrogen, was added n-BuLi (50.63 mL of a 1.6 M solution in hexane, 81.0 mmol) and stirring was continued at this temperature for 20 min. The resultant suspension was then treated, dropwise, with N-(tert-butoxycarbonyl)-L-valine methyl ester (7.5 g, 32.4 mmol) in THF (10 mL) and stirring was continued at -78 ºC for 6 h. After this time, the dry ice-actone bath was removed and the mixture was allowed to warm to RT with continued stirring for 16 h. The reaction was then quenched with sat. aq. NH 4 Cl (200 mL) and diluted with diethyl ether (400 mL). The aqueous layer was separated and the organic layer was washed sequentially with sat. aq. 13 mmol). The column was then eluted successively with MeOH (100 mL), THF (120 mL) and acetone (120 mL). The three organic fractions were pooled and concentrated under reduced pressure to afford a clear colourless oil containing the desired compound 8 (3.24 g, 2.61 mmol, 94% H-NMR). This material was suspended in EtOAc (20 mL) and treated with sodium carbonate (10 mL of a 1M aqueous solution), whilst being magnetically stirred at r.t. under an atmosphere of nitrogen. After 15 min, the aqueous layer was separated and discarded. The organic layer was washed with water (2 x 10 mL), then dried (MgSO 4 ), and concentrated under reduced pressure to afford compound 8 (2.06 g, 1.66 mmol, 93%). Subjection of this material to chiral HPLC analysis (Chiralpak™ AD-H 1196 analytical column, 2:98 v/v isopropanol-hexane elution, flow rate 1.0 mL/min) confirmed that it had been obtained in 93% d.e: R t 12.85 (major diastereomer), 16.96 min (minor diastereomer). Compound ent-8 was prepared using the same protocols as those described for the preparation of compound 8, using compound ent-7 (3.5 g, 3.13 mmol) as starting material. Purification via the same means (FSPE & precipitation of tosylate) afforded compound ent-8 (2.25 g, 1.6 mmol, 51% over the two steps). This material was identical, as judged by 1 H-NMR, 13 C-NMR,
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F-NMR and low resolution mass spectrometric analysis, as well as chromatographic behaviour (TLC and flashcolumn chromatography), with the optical antipode compound 8 reported above. (R)-2-(Benzyloxyaminomethyl)-3-phenylpropionic acid (9) and recovery of compound 6 via FSPE. A magnetically stirred solution of compound 8 (2.06 g, 1.66 mmol, 93% d.e), in THF (80 mL) and water (10 mL), maintained at 0 ºC under an atmosphere of nitrogen, was treated with H 2 O 2 (40 mL of a 30% aqueous solution), followed by LiOH (160 mL of a 4.5% aqueous solution). The reaction mixture was stirred at this temperature for 45 min, before being quenched via addition of cold sat. aq. sodium sulfite (40 mL), and allowed to warm to RT over the course of 30 min. The resultant suspension was extracted with EtOAc (4 x 100 mL) and the organic extracts dried (MgSO 4 ), and concentrated under reduced pressure to give a residue which was subjected to FSPE. A commercially available Fluoroflash™ cartridge (20 g) was preconditioned by passing through MeOH / H 2 O (60 mL of an 80 : 20 v/v mixture) under positive pressure. The residue was loaded on to the top of the column, using DMF (4 mL) as the loading solvent. The column was then eluted with MeOH / H 2 O (60 mL of an 80 : 20 v/v mixture).
